Molecular response assessment by quantitative real-time polymerase chain reaction after induction therapy in NPM1-mutated patients identifies those at high risk of relapse

Lignende værker

• The NPM1 Mutation Type Has No Impact on Survival in Cytogenetically Normal AML
  af: Pastore, Friederike, et al.
  Udgivet: (2014)
• Persistence of pre-leukemic clones during first remission and risk of relapse in acute myeloid leukemia
  af: Rothenberg-Thurley, Maja, et al.
  Udgivet: (2018)
• Long-term follow-up of cytogenetically normal CEBPA-mutated AML
  af: Pastore, Friederike, et al.
  Udgivet: (2014)
• Combined Molecular and Clinical Prognostic Index for Relapse and Survival in Cytogenetically Normal Acute Myeloid Leukemia
  af: Pastore, Friederike, et al.
  Udgivet: (2014)
• RUNX1 mutations in cytogenetically normal acute myeloid leukemia are associated with a poor prognosis and up-regulation of lymphoid genes
  af: Greif, Philipp A., et al.
  Udgivet: (2012)